Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Titte R Srinivas

Showing results (1-10 of 70) with videos related to

Pageof 7
Sort By:
Nature Reviews. Nephrology|December 21, 2011
Transplantation in 2011: New agents, new ideas and new hopeTitte R Srinivas, Bruce Kaplan
Clinical Transplantation|April 21, 2015
Identifying endpoints to predict the influence of immunosuppression on long-term kidney graft survivalTitte R Srinivas, Federico Oppenheimer
Advances in Chronic Kidney Disease|June 27, 2012
Do living kidney donors have CKD?Titte R Srinivas, Emilio D Poggio
Drug Design, Development and Therapy|July 24, 2015
Authors' replyMaria Aurora Posadas Salas, Titte R Srinivas
Clinical Journal of the American Society of Nephrology : CJASN|March 20, 2008
Minimizing immunosuppression, an alternative approach to reducing side effects: objectives and interim resultTitte R Srinivas, Herwig-Ulf Meier-Kriesche
Seminars in Nephrology|February 5, 2013
Obesity and kidney transplantationTitte R Srinivas, Herwig-Ulf Meier-Kriesche
Contributions to Nephrology|August 25, 2006
Obesity and kidney transplantationTitte R Srinivas, Herwig-Ulf Meier-Kriesche
Drug Design, Development and Therapy|September 12, 2014
Update on the clinical utility of once-daily tacrolimus in the management of transplantationMaria Aurora Posadas Salas, Titte R Srinivas
Current Hypertension Reports|August 13, 2013
Hypertension after kidney transplantation: a pathophysiologic approachBeje Thomas, David J Taber, Titte R Srinivas
Nature Clinical Practice. Nephrology|July 20, 2007
Hyperfiltration: a sign of poor things to come in individuals with metabolic syndromeJogiraju Tantravahi, Titte R Srinivas, Richard J Johnson
Pageof 7

Showing results (1-10 of 70) with videos related to

Sort By:
Pageof 7
Nature Reviews. Nephrology|December 21, 2011
Transplantation in 2011: New agents, new ideas and new hopeTitte R Srinivas, Bruce Kaplan
Clinical Transplantation|April 21, 2015
Identifying endpoints to predict the influence of immunosuppression on long-term kidney graft survivalTitte R Srinivas, Federico Oppenheimer
Advances in Chronic Kidney Disease|June 27, 2012
Do living kidney donors have CKD?Titte R Srinivas, Emilio D Poggio
Drug Design, Development and Therapy|July 24, 2015
Authors' replyMaria Aurora Posadas Salas, Titte R Srinivas
Clinical Journal of the American Society of Nephrology : CJASN|March 20, 2008
Minimizing immunosuppression, an alternative approach to reducing side effects: objectives and interim resultTitte R Srinivas, Herwig-Ulf Meier-Kriesche
Seminars in Nephrology|February 5, 2013
Obesity and kidney transplantationTitte R Srinivas, Herwig-Ulf Meier-Kriesche
Contributions to Nephrology|August 25, 2006
Obesity and kidney transplantationTitte R Srinivas, Herwig-Ulf Meier-Kriesche
Drug Design, Development and Therapy|September 12, 2014
Update on the clinical utility of once-daily tacrolimus in the management of transplantationMaria Aurora Posadas Salas, Titte R Srinivas
Current Hypertension Reports|August 13, 2013
Hypertension after kidney transplantation: a pathophysiologic approachBeje Thomas, David J Taber, Titte R Srinivas
Nature Clinical Practice. Nephrology|July 20, 2007
Hyperfiltration: a sign of poor things to come in individuals with metabolic syndromeJogiraju Tantravahi, Titte R Srinivas, Richard J Johnson
Pageof 7